Volume 23 Issue 5
May  2025
Turn off MathJax
Article Contents
ZHANG Aimu, LIU Sanwei, SHI Zhanhong, ZHOU Fan. Correlation analysis of anxiety and depression with bisphosphonate treatment compliance and bone mineral density changes in perimenopausal population[J]. Chinese Journal of General Practice, 2025, 23(5): 819-822. doi: 10.16766/j.cnki.issn.1674-4152.004009
Citation: ZHANG Aimu, LIU Sanwei, SHI Zhanhong, ZHOU Fan. Correlation analysis of anxiety and depression with bisphosphonate treatment compliance and bone mineral density changes in perimenopausal population[J]. Chinese Journal of General Practice, 2025, 23(5): 819-822. doi: 10.16766/j.cnki.issn.1674-4152.004009

Correlation analysis of anxiety and depression with bisphosphonate treatment compliance and bone mineral density changes in perimenopausal population

doi: 10.16766/j.cnki.issn.1674-4152.004009
Funds:

 2024ZL997

 Y20210357

  • Received Date: 2024-06-05
    Available Online: 2025-08-14
  •   Objective  To analyze the correlation between anxiety and depression in the perimenopausal population, compliance with bisphosphonate treatment and changes in bone mineral density (BMD), and to provide evidence for early intervention of anxiety and depression in women.  Methods  A total of 248 perimenopausal women diagnosed and treated in Wenzhou Central Hospital from February 2022 to February 2024 were selected by convenient sampling method, and their anxiety and depression were evaluated by Zung self-rating anxiety scale (SAS) and Zung self-rating depression scale (SDS). According to the results, they were divided into an anxiety and depression group (SAS score ≥50 and SDS score ≥53) and a non-anxiety and depression group. The general data, bisphosphonate treatment compliance, and BMD of the two groups were analyzed and compared, and the related factors affecting the patients ' anxiety and depression were analyzed by multivariate logistic regression. At the same time, the anxiety and depression group was divided into mild, moderate, and severe according to the SAS score and SDS score. Pearson test was used to analyze the correlation between anxiety and depression scores and bisphosphonate treatment compliance, and BMD changes in perimenopausal women.  Results  Among the 245 perimenopausal patients who completed the investigation, 71 cases developed anxiety and depression, with an incidence rate of 28.98%. By multivariate logistic regression analysis, high BMI, no spouse, and high perimenopausal symptom severity score were independent risk factors for anxiety and depression in perimenopausal women, while no chronic disease, high medication compliance, and high BMD were independent protective factors for anxiety and depression in perimenopausal women. Anxiety score of perimenopausal women was negatively correlated with bisphosphonate treatment compliance and BMD changes.  Conclusion  The incidence of anxiety and depression in the perimenopausal population is high, which is negatively correlated with the compliance of bisphosphonate treatment and the change in BMD.

     

  • loading
  • [1]
    GRIGOLON R B, CEOLIN G, DENG Y, et al. Effects of nutritional interventions on the severity of depressive and anxiety symptoms of women in the menopausal transition and menopause: a systematic review, meta-analysis, and meta-regression[J]. Menopause, 2023, 30(1): 95-107.
    [2]
    HERSON M, KULKARNI J. Hormonal agents for the treatment of depression associated with the menopause[J]. Drugs Aging, 2022, 39(8): 607-618.
    [3]
    KANTO A, KOTANI Y, MURAKAMI K, et al. Risk factors for future osteoporosis in perimenopausal Japanese women[J]. Menopause, 2022, 29(10): 1176-1183.
    [4]
    KISTLER-FISCHBACHER M, YONG J S, WEEKS B K, et al. A comparison of bone-targeted exercise with and without antiresorptive bone medication to reduce indices of fracture risk in postmenopausal women with low bone mass: the MEDEX-OP randomized controlled trial[J]. J Bone Miner Res, 2021, 36(9): 1680-1693.
    [5]
    MARTINO G, BELLONE F, VICARIO C M, et al. Anxiety levels predict bone mineral density in postmenopausal women undergoing oral bisphosphonates: a two-year follow-up[J]. Int J Environ Res Public Health, 2021, 18(15): 8144. DOI: 10.3390/ijerph18158144.
    [6]
    梁丽娟, 张秋君, 别双桂. 更年期综合征女性焦虑, 抑郁情绪与心理弹性间关系[J]. 中国健康心理学杂志, 2021, 29(2): 161-164.

    LIANG L J, ZHANG Q J, BIE S G. Correlation between anxiety, depression and psychological elasticity of women with menopausal syndrome[J]. China Journal of Health Psychology, 2021, 29(2): 161-164.
    [7]
    HERROU J, GODART N, ETCHETO A, et al. Absence of relationships between depression and anxiety and bone mineral density in patients hospitalized for severe anorexia nervosa[J]. Eat Weight Disord, 2021, 26(6): 1975-1984.
    [8]
    ROEBUCK G, MAZZOLINI M, MOHEBBI M, et al. Anxiety disorders are associated with reduced bone mineral density in men: findings from the Geelong Osteoporosis Study[J]. Acta Psychiatr Scand, 2023, 148(1): 47-59.
    [9]
    SUN Y, WANG M, ZHOU Y, et al. The mediating effect of family function and medication adherence between symptoms and mental disability among Chinese patients with schizophrenia: a cross-sectional study[J]. Psychol Health Med, 2019, 24(5): 559-569.
    [10]
    SHUNMUGASUNDARAM C, DHILLON H M, BUTOW P N, et al. Patient-reported anxiety and depression measures for use in Indian head and neck cancer populations: a psychometric evaluation[J]. J Patient Rep Outcomes, 2021, 5(1): 44.
    [11]
    ZEITLIN J, PARIDES M K, LANE J M, et al. A clinical prediction model for 10-year risk of self-reported osteoporosis diagnosis in pre-and perimenopausal women[J]. Arch Osteoporos, 2023, 18(1): 78.
    [12]
    刘美辰, 刘春梅, 杨青兰, 等. 围绝经期门诊患者的认知与行为现状及影响因素分析[J]. 安徽医学, 2024, 45(10): 1311-1315.

    LIU M C, LIU C M, YANG Q L, et al. Analysis of cognition and behavior status of perimenopausal outpatients and its influencing factors[J]. Anhui Medical Journal, 2024, 45(10): 1311-1315.
    [13]
    贾庆升. 围绝经期女性焦虑和抑郁情绪影响因素分析[J]. 中国妇幼保健, 2021, 36(9): 1974-1977.

    JIA Q S. Analysis of influencing factors of anxiety and depression in perimenopausal women[J]. China Maternal and Child Health Care, 2021, 36(9): 1974-1977.
    [14]
    王静, 胡艳丽, 邓君霞. 丽水地区女性围绝经期抑郁和焦虑发生情况及影响因素分析[J]. 中国妇幼保健, 2021, 36(12): 2851-2854.

    WANG J, HU Y L, DENG J X. Analysis of the occurrence and influencing factors of female perimenopausal depression and anxiety in Lishui area[J]. China Maternal and Child Health Care, 2021, 36(12): 2851-2854.
    [15]
    方肖肖, 许婉纯, 卢珊, 等. 中国城乡慢性病患者健康相关生命质量及其影响因素分析[J]. 中国公共卫生, 2022, 38(7): 833-837.

    FANG X X, XU W C, LU S, et al. Health-related quality of life and its influencing factors among urban and rural chronic disease patients in China[J]. Chinese Journal of Public Health, 2022, 38(7): 833-837.
    [16]
    刘超, 梁超. 围绝经期女性焦虑和抑郁状况调查及影响因素分析[J]. 中国妇幼保健, 2022, 37(18): 3302-3306.

    LIU C, LIANG C. Investigation on anxiety and depression of perimenopausal women and analysis of influencing factors[J]. China Maternal and Child Health Care, 2022, 37(18): 3302-3306.
    [17]
    HE B, LYU Q, YIN L, et al. Depression and osteoporosis: a Mendelian randomization study[J]. Calcif Tissue Int, 2021, 109(6): 675-684.
    [18]
    宋徽江, 刘怀磊, 杨丽萍. 社区绝经后妇女骨质疏松症筛查结果及影响因素研究[J]. 中华全科医学, 2020, 18(7): 1157-1160. doi: 10.16766/j.cnki.issn.1674-4152.001454

    SONG H J, LIU H L, YANG L P. Screening results and influencing factors of osteoporosis in postmenopausal women in community[J]. Chinese Journal of General Practice, 2020, 18(7): 1157-1160. doi: 10.16766/j.cnki.issn.1674-4152.001454
    [19]
    CAI Q, YE L, HORNE R, et al. Medication adherence in adult Chinese patients with asthma: role of illness perceptions and medication beliefs[J]. J Asthma, 2022, 59(7): 1445-1451.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Article Metrics

    Article views (6) PDF downloads(0) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return